Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

SPRYSPRY
23 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ARS PHARMACEUTICALS INC

CITADEL ADVISORS LLC holds 531,063 shares of SPRY (ARS PHARMACEUTICALS INC), worth $4.3M as of 2026-Q2. The position was decreased (-70.0% shares). SPRY represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$4.3M

Current Shares

531,063

Total Value Change

-$2.1M

Total Shares Change

+392,925

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
531,063
-70.0%
$4.3M0.0%$8.01
0
2026-Q1
Decreased
1.8M
-9.3%
$14.2M0.0%$8.87
0
2025-Q4
Increased
2M
+23.2%
$22.8M0.0%$11.64
35
2025-Q3
Decreased
1.6M
-29.3%
$15.9M0.0%$9.72
0
2025-Q2
Increased
2.2M
+179.8%
$39.1M0.0%$18.20
47
2025-Q1
Decreased
801,290
-0.5%
$10.1M0.0%$12.49
0
2024-Q4
Increased
805,456
+219.0%
$8.5M0.0%$10.62
44
2024-Q3
Increased
252,499
+178.2%
$3.7M0.0%$14.32
43
2024-Q2
Decreased
90,758
-19.0%
$772,3510.0%$8.51
0
2024-Q1
Increased
112,065
+252.4%
$1.1M0.0%$10.22
41
2023-Q4
Increased
31,803
+175.6%
$174,2800.0%$5.48
25
2023-Q3
Decreased
11,538
-94.8%
$43,6140.0%$3.78
0
2023-Q2
Increased
220,348
+392.1%
$1.5M0.0%$6.61
41
2023-Q1
Increased
44,776
+439.7%
$291,4910.0%$6.73
38
2022-Q4
Decreased
8,297
-91.5%
$70,7740.0%$8.53
0
2022-Q3
Decreased
97,470
-57.9%
$515,0000.0%$5.29
0
2022-Q2
Increased
231,666
+18.7%
$982,0000.0%$4.41
29
2022-Q1
Increased
195,156
+108.6%
$685,0000.0%$3.52
40
2021-Q4
Increased
93,565
+25.6%
$623,0000.0%$6.60
30
2021-Q3
Increased
74,492
+115.0%
$743,0000.0%$10.55
40
2021-Q2
New
34,648
-
$1.1M0.0%$31.54
35
2021-Q1
Exited
0
-100.0%
$00.0%$40.57
0
2020-Q4
New
138,138
-
$6.4M0.0%$42.04
38

Other major holders of SPRY: FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used